Calendar Year Performance 2014Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023
+ 6.2 %
- 0.5 %
+ 21.2 %
+ 24.1 %
- 6.9 %
+ 5.2 %
+ 6.5 %
+ 20.0 %
- 17.2 %
+ 10.9 %
Net Asset Value
218.04 £
Asset Under Management
127 M €
Market
Emerging markets
SFDR - Fund Classification
Article 8
Data as of: 2 Oct 2024.
Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
You may find in this section information on characteristics, costs, and risks of the Fund. If you have any questions, please do not hesitate to contact Carmignac for further details and assistance.
Investment Universe and Objective
Equity fund invested in small and mid-capitalisations of emerging countries, as well as less covered frontier markets. The investment process combines a fundamental top-down approach with a disciplined bottom-up analysis and a socially responsible approach in order to identify the best investment opportunities by seeking companies offering long-term growth potential and attractive cash generation, in underpenetrated sectors and in countries with healthy fundamentals. The Fund aims to outperform its reference indicator over 5 years.
Characteristics
General Characteristics
Management Company
Carmignac Gestion Luxembourg S.A
Legal Form
Luxembourg SICAV sub-fund
ISIN
LU0992630086
Bloomberg
CAREMFG LX
SEDOL
BGP6SY4
CITI
JWKL
Mex
0FABDE
Lipper
68239052
Detailed Characteristics
SFDR - Fund Classification
Article 8
Risk Indicator
5/7
1
2
3
4
5
6
7
Lowest risk
Highest risk
Recommended minimum investment horizon
5 years
Management
Equity strategies
Reference Indicator
50% MSCI EM SmallCap (GBP) + 50% MSCI EM MidCap (GBP) (Reinvested net dividends rebalanced quarterly)
Daily, except on French public holidays for FCP/SICAV; UK bank holidays for OEIC; Stock market holidays in the US, China and Hong Kong for China New Economy Funds. Subscribe to NAVs
Order Placement Cut-Off Time
Before 18:00 CET
Fees
One-off charges taken before or after you invest
Maximum subscription fees paid to distributors
0,00%
Redemption Fees
0,00%
Conversion Fee
-
Charges taken from the fund over a year
Ongoing Charges
1.50%
Management Fees
1,20% MAX
Charges taken from the fund under certain specific conditions
Performance Fees
-
Risks
Main Risks of the Fund
Equity
The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Emerging Markets
Operating conditions and supervision in "emerging" markets may deviate from the standards prevailing on the large international exchanges and have an impact on prices of listed instruments in which the Fund may invest.
Currency
Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.
Liquidity
Temporary market distortions may have an impact on the pricing conditions under which the Fund might be caused to liquidate, initiate or modify its positions.
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
Unsupported browserWe've noticed that your browser is no longer supported. To ensure optimal performance and security while using our website, we recommend updating your browser or other relevant software. Thank you for your understanding!